Treatment with ranolazine increases the number of antitumour lymphocytes that infiltrate the tumour and favour the action of immunotherapy (IMAGE)

Institute for Research in Biomedicine (IRB Barcelona)

Treatment with ranolazine increases the number of antitumour lymphocytes that infiltrate the tumour and favour the action of immunotherapy

Caption

NK-type antitumour lymphocytes are stained in green and tumour cells in blue.

Credit

Navarrabiomed

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.